BIO Announces CEO Plenary Speakers for the 2008 World Congress on Industrial Biotechnology and Bioprocessing
WASHINGTON, D.C. (Thursday, January 31, 2008) - The Biotechnology Industry Organization (BIO) today announced that Jeff Broin, president and CEO of POET, Richard Hamilton, CEO of Ceres, and Steen Riisgaard, CEO of Novozymes, will share perspectives on the evolution of the industrial biotech value chain at the World Congress on Industrial Biotechnology & Bioprocessing.
The conference will take place April 27-30, 2008 at the Hilton Chicago, in Chicago, Ill. The World Congress is the only global conference dedicated solely to the most recent advancements in industrial biotechnology.
“The commercial development of cellulosic biofuels and related biobased products could add more than $12 billion to the U.S. economy and more than 20,000 jobs for rural areas. The World Congress will highlight the technological advancements in industrial biotechnology as well as the public policy and investment necessary to ensure that growth," said Brent Erickson, executive vice president of the Industrial and Environmental Section at BIO. “This is an ideal forum for academics, government officials, and business leaders from around the world to learn about and discuss the new and innovative technologies affecting our industry.”
Additional plenary speakers include:
· David Berry, principal, Flagship Ventures
· Mauro Gregorio, business director, Alternative Feedstocks at Dow Chemical
· Weiming Jiang, president, DSM China
· Steve Koonin, chief scientist, BP
· David Morris, vice president, Institute for Local Self Reliance
· Pradip Mukerji, group manager, Strategic Expansion, Abbott Laboratories
· Jim Newcomb, managing director, Research, Bio Economic Research Associates
· Roger Wyse, managing director and general partner, Burrill & Company
A breakout program will feature tracks on issues pertaining to biofuels and bioenergy; renewable feedstocks; renewable chemicals and biomaterials; fine chemicals; food ingredients and pharmaceuticals; and business development, infrastructure, and public policy. The event also features an exhibit hall, business partnering and networking opportunities, and a poster reception.
The 2008 World Congress on Industrial Biotechnology and Bioprocessing will be co-hosted by the American Chemical Society, the National Agricultural Biotechnology Council and Biotech Canada.
Advance media registration is available online through April 22, 2008, and is complimentary for credentialed members of the news media. To register, please visit: http://www.bio.org/worldcongress2008/media/.
For more information on the 2008 World Congress on Industrial Biotechnology and Bioprocessing, please visit the conference webpage at http://www.bio.org/worldcongress2008/.
Upcoming BIO Events
· BIO CEO & Investor Conference
February 11-13, 2008
New York, NY
· Partnering for Global Health
March 10-12, 2008
· BIO-Europe Spring
April 7-9, 2008
· BIO National Venture Conference
April 22-23, 2008
· World Congress on Industrial Biotechnology & Bioprocessing
April 27-30, 2008
· 2008 BIO International Convention
June 17-20, 2008
San Diego, Calif.
BIO represents more than 1,150 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. BIO also produces the annual BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.